MwanzoINRLF • OTCMKTS
add
Valneva SE
Bei iliyotangulia
$ 1.98
Bei za mwaka
$ 1.98 - $ 5.40
Thamani ya kampuni katika soko
298.86M EUR
Wastani wa hisa zilizouzwa
794.00
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
EPA
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (EUR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 45.82M | 20.36% |
Matumizi ya uendeshaji wa biashara | 13.66M | 234.94% |
Mapato halisi | -9.24M | 73.01% |
Kiwango cha faida halisi | -20.16 | 77.58% |
Mapato kwa kila hisa | -0.15 | 71.80% |
EBITDA | -12.40M | -16.52% |
Asilimia ya kodi ya mapato | 28.71% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (EUR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 156.34M | -8.71% |
Jumla ya mali | 516.61M | -0.75% |
Jumla ya dhima | 299.14M | -17.59% |
Jumla ya hisa | 217.47M | — |
hisa zilizosalia | 140.53M | — |
Uwiano wa bei na thamani | 1.28 | — |
Faida inayotokana na mali | -6.31% | — |
Faida inayotokana mtaji | -7.80% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (EUR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -9.24M | 73.01% |
Pesa kutokana na shughuli | -10.48M | 85.32% |
Pesa kutokana na uwekezaji | -15.38M | -751.14% |
Pesa kutokana na ufadhili | 51.86M | 45.62% |
Mabadiliko halisi ya pesa taslimu | 24.92M | 175.16% |
Mtiririko huru wa pesa | -41.46M | 41.47% |
Kuhusu
Valneva SE is a French biotech company headquartered in Saint-Herblain, France, developing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2013
Tovuti
Wafanyakazi
700
